These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 26360914)

  • 1. DNA methylation profiles distinguish different subtypes of gastroenteropancreatic neuroendocrine tumors.
    How-Kit A; Dejeux E; Dousset B; Renault V; Baudry M; Terris B; Tost J
    Epigenomics; 2015; 7(8):1245-58. PubMed ID: 26360914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signaling networks and the feasibility of computational analysis in gastroenteropancreatic neuroendocrine tumors.
    Chen P; Wang Q; Xie J; Kwok HF
    Semin Cancer Biol; 2019 Oct; 58():80-89. PubMed ID: 31054326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastroenteropancreatic neuroendocrine neoplasms: genes, therapies and models.
    Kawasaki K; Fujii M; Sato T
    Dis Model Mech; 2018 Feb; 11(2):. PubMed ID: 29590641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor suppressor genes in the 9p21 gene cluster are selective targets of inactivation in neuroendocrine gastroenteropancreatic tumors.
    Lubomierski N; Kersting M; Bert T; Muench K; Wulbrand U; Schuermann M; Bartsch D; Simon B
    Cancer Res; 2001 Aug; 61(15):5905-10. PubMed ID: 11479232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of 320 gastroenteropancreatic neuroendocrine tumors identifies TS expression as independent biomarker for survival.
    Lee HS; Chen M; Kim JH; Kim WH; Ahn S; Maeng K; Allegra CJ; Kaye FJ; Hochwald SN; Zajac-Kaye M
    Int J Cancer; 2014 Jul; 135(1):128-37. PubMed ID: 24347111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutaminases in slowly proliferating gastroenteropancreatic neuroendocrine neoplasms/tumors (GEP-NETs): Selective overexpression of mRNA coding for the KGA isoform.
    Szeliga M; Ćwikła J; Obara-Michlewska M; Cichocki A; Albrecht J
    Exp Mol Pathol; 2016 Feb; 100(1):74-8. PubMed ID: 26581715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical application of microRNA testing in neuroendocrine tumors of the gastrointestinal tract.
    Vicentini C; Fassan M; D'Angelo E; Corbo V; Silvestris N; Nuovo GJ; Scarpa A
    Molecules; 2014 Feb; 19(2):2458-68. PubMed ID: 24566314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methyltransferases 1, 3a, and 3b overexpression and clinical significance in gastroenteropancreatic neuroendocrine tumors.
    Rahman MM; Qian ZR; Wang EL; Yoshimoto K; Nakasono M; Sultana R; Yoshida T; Hayashi T; Haba R; Ishida M; Okabe H; Sano T
    Hum Pathol; 2010 Aug; 41(8):1069-78. PubMed ID: 20381114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High VEGF serum values are associated with locoregional spread of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
    Cigrovski Berković M; Čačev T; Catela Ivković T; Marout J; Ulamec M; Zjačić-Rotkvić V; Kapitanović S
    Mol Cell Endocrinol; 2016 Apr; 425():61-8. PubMed ID: 26805636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas.
    Garcia-Carbonero R; Sorbye H; Baudin E; Raymond E; Wiedenmann B; Niederle B; Sedlackova E; Toumpanakis C; Anlauf M; Cwikla JB; Caplin M; O'Toole D; Perren A;
    Neuroendocrinology; 2016; 103(2):186-94. PubMed ID: 26731334
    [No Abstract]   [Full Text] [Related]  

  • 11. A novel germline mutation at exon 10 of MEN1 gene: a clinical survey and positive genotype-phenotype analysis of a MEN1 Italian family, including monozygotic twins.
    Palermo A; Capoluongo E; Del Toro R; Manfrini S; Pozzilli P; Maggi D; Defeudis G; Pantano F; Coppola R; Di Matteo FM; Raffaelli M; Concolino P; Falchetti A
    Hormones (Athens); 2018 Sep; 17(3):427-435. PubMed ID: 30083881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the BRAF V600E mutation in gastroenteropancreatic neuroendocrine tumors.
    Park C; Ha SY; Kim ST; Kim HC; Heo JS; Park YS; Lauwers G; Lee J; Kim KM
    Oncotarget; 2016 Jan; 7(4):4024-35. PubMed ID: 26684240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global DNA methylation patterns through an array-based approach in small intestinal neuroendocrine tumors.
    Verdugo AD; Crona J; Starker L; Stålberg P; Åkerström G; Westin G; Hellman P; Björklund P
    Endocr Relat Cancer; 2014 Feb; 21(1):L5-7. PubMed ID: 24192231
    [No Abstract]   [Full Text] [Related]  

  • 14. Expression and Molecular Regulation of the Cox2 Gene in Gastroenteropancreatic Neuroendocrine Tumors and Antiproliferation of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs).
    Gao F; Zafar MI; Jüttner S; Höcker M; Wiedenmann B
    Med Sci Monit; 2018 Nov; 24():8125-8140. PubMed ID: 30420588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Genetic profile of gastroenteropancreatic neuroendocrine tumors].
    Cabezas Agrícola JM
    Endocrinol Nutr; 2009 Apr; 56 Suppl 2():16-9. PubMed ID: 19627765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Associated gastroenteropancreatic neuroendocrine tumours to familiar syndromes].
    Lecumberri Pascual E
    Endocrinol Nutr; 2009 Apr; 56 Suppl 2():10-5. PubMed ID: 19627764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating gastroenteropancreatic neuroendocrine tumors through microRNA sequencing.
    Panarelli N; Tyryshkin K; Wong JJM; Majewski A; Yang X; Scognamiglio T; Kim MK; Bogardus K; Tuschl T; Chen YT; Renwick N
    Endocr Relat Cancer; 2019 Jan; 26(1):47-57. PubMed ID: 30021866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intertumoral lineage diversity and immunosuppressive transcriptional programs in well-differentiated gastroenteropancreatic neuroendocrine tumors.
    Hoffman SE; Dowrey TW; Villacorta Martin C; Bi K; Titchen B; Johri S; DelloStritto L; Patel M; Mackichan C; Inga S; Chen J; Grimaldi G; Napolitano S; Wakiro I; Wu J; Yeung J; Rotem A; Sicinska E; Shannon E; Clancy T; Wang J; Denning S; Brais L; Besson NR; Pfaff KL; Huang Y; Kao KZ; Rodig S; Hornick JL; Vigneau S; Park J; Kulke MH; Chan J; Van Allen EM; Murphy GJ
    Sci Adv; 2023 Sep; 9(39):eadd9668. PubMed ID: 37756410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation profiling in MEN1-related pancreatic neuroendocrine tumors reveals a potential epigenetic target for treatment.
    Conemans EB; Lodewijk L; Moelans CB; Offerhaus GJA; Pieterman CRC; Morsink FH; Dekkers OM; de Herder WW; Hermus AR; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; Brosens LAA; Dreijerink KMA; Borel Rinkes IHM; Timmers HTM; Valk GD; Vriens MR
    Eur J Endocrinol; 2018 Sep; 179(3):153-160. PubMed ID: 29903750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomere length abnormalities and telomerase RNA component expression in gastroenteropancreatic neuroendocrine tumors.
    Kim HS; Lee HS; Nam KH; Choi J; Kim WH
    Anticancer Res; 2015 Jun; 35(6):3501-10. PubMed ID: 26026117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.